BMEA logo

BMEABiomea Fusion Inc

$1.27
$0.10
(7.30%)
Today
Closed $1.27
$0.03
(2.36%)
After Hours
Updated: 07:59 PM EDT
Reported EarningsMay 11
Mkt Cap$91.82M
Vol1.36M

About

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in San Carlos, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
41

Frequently Asked Questions

What is Market Cap of Biomea Fusion Inc?
What is the 52-week high for Biomea Fusion Inc?
What is the 52-week low for Biomea Fusion Inc?
What is Biomea Fusion Inc stock price today?
What was Biomea Fusion Inc stock price yesterday?
What is the PE ratio of Biomea Fusion Inc?
What is the Price-to-Book ratio of Biomea Fusion Inc?
What is the 50-day moving average of Biomea Fusion Inc?
How many employees does Biomea Fusion Inc have?

Advertisement|Remove ads.